Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.
Neuroscience
Our scientists and oncologists strive to give patients improved treatment outcomes and a life beyond cancer by developing therapies that elevate the standards of care.
A career at AbbVie
Our ~50,000 employees around the world focus on discovering and delivering transformational medicines and products.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A.
